US: S&P 500 eases after vaccine news rally
[NEW YORK] The S&P 500 dipped at the open on Tuesday as excitement over signs of a first successful late-stage Covid-19 vaccine trial faded, while investors continued to pull money out of the big tech companies that have benefited most from the pandemic.
The Dow Jones Industrial Average rose 96.20 points, or 0.33 per cent, at the open to 29,254.17.
The S&P 500 opened lower by 7.24 points, or 0.20 per cent, at 3,543.26, while the Nasdaq Composite dropped 91.34 points, or 0.78 per cent, to 11,622.44 at the opening bell.
REUTERS
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Capital Markets & Currencies
STI climbs 0.8% on Friday, tracking regional rally
JPMorgan says India index inclusion on track, clients ready
Asia: Markets mostly rise as US data boosts rate hopes
Singapore stocks advance at Friday’s open, STI up 0.4%
Stocks to watch: OCBC, Sri Trang Gloves, Wilmar, Great Eastern, F&N, SingPost
Europe: Stoxx 600 ends at record high; BBVA weighs on Spain